Dexcom (DXCM) Change in Inventory (2010 - 2026)

Dexcom (DXCM) has 17 years of Change in Inventory data on file, last reported at $65.2 million in Q1 2026.

• Change in Inventory for Q1 2026 came in at $65.2 million, up 1151.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $135.1 million (up 344.3% YoY), and the FY2025 annual result was $63.7 million, up 613.71% from the prior year.
• Change in Inventory climbed to $65.2 million in Q1 2026 per DXCM's latest filing, from $17.8 million in the prior quarter.
• Over five years, Change in Inventory peaked at $78.6 million in Q3 2023 and troughed at -$32.7 million in Q4 2024.
• A 5-year average of $18.8 million and a median of $17.8 million in 2025 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2022 and 2023: Change in Inventory slumped 223.96% in 2022, then surged 5136.36% in 2023.
• A 5-year view of Change in Inventory shows it stood at -$5.7 million in 2022, then soared by 1135.09% to $59.0 million in 2023, then sank by 155.42% to -$32.7 million in 2024, then jumped by 154.43% to $17.8 million in 2025, then soared by 266.29% to $65.2 million in 2026.
• Business Quant data shows DXCM's Change in Inventory at $65.2 million in Q1 2026, $17.8 million in Q4 2025, and $33.6 million in Q3 2025.